Similar companies
Did Oramed Pharmaceuticals Beat Earnings?
Oramed Pharmaceuticals (ORMP) reported Q1 '26 revenue of $0, down 100.0% year-over-year, with reported EPS of $0.91.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Oramed Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full ORMP stock analysis or the earnings calendar for upcoming reports.
ORMP Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q4 '25 | $-0.08 | $0.25 | Beat +412.5% |
| Q3 '25 | $-0.04 | $1.13 | Beat +2,925.0% |
| Q2 '25 | $-0.04 | $0.31 | Beat +875.0% |
| Q2 '24 | $-0.02 | $0.22 | Beat +1,200.0% |
| Q1 '24 | $0.02 | $0.04 | Beat +100.0% |
Oramed Pharmaceuticals Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2M | — | — | — | — | — |
| Gross margin | — | — | 0.7% | — | — | — | — | — |
| Operating margin | — | — | -225.0% | — | — | — | — | — |
| Net income | -20M | -10M | -7.6M | 13M | 48M | 10M | 38M | 78M |
| Net margin | — | — | -382.1% | — | — | — | — | — |
| EPS | — | — | — | $0.31 | $1.13 | $0.25 | $0.91 | — |
Oramed Pharmaceuticals Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Oramed Pharmaceuticals’s quarterly revenue moved from $0 to $0. Oramed Pharmaceuticals has beaten Wall Street EPS estimates in 5 of its last 5 reported quarters.
When Is Oramed Pharmaceuticals’s Next Earnings Date?
Oramed Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q1 '26. For the confirmed upcoming date — and every other company reporting soon — see the ORMP earnings calendar.
Frequently Asked Questions: Oramed Pharmaceuticals Earnings
Oramed Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Oramed Pharmaceuticals reported Q1 '26 EPS of $0.91 on revenue of $0 (-100.0% YoY). Oramed Pharmaceuticals reported EPS of $0.91.
Oramed Pharmaceuticals reported Q1 '26 revenue of $0, down 100.0% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ORMP AI Score.
